| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 9.21e-06 | 1412 | 22 | 9 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.20e-05 | 1459 | 22 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.41e-05 | 560 | 22 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.56e-05 | 566 | 22 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.13e-04 | 739 | 22 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.66e-04 | 1244 | 22 | 7 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 3.04e-04 | 1271 | 22 | 7 | GO:0000987 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.54e-04 | 37 | 22 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.26e-03 | 1160 | 22 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.95e-03 | 229 | 22 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.81e-03 | 1356 | 22 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.03e-03 | 562 | 22 | 4 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.30e-03 | 303 | 22 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | ATPase binding | 6.24e-03 | 108 | 22 | 2 | GO:0051117 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.53e-03 | 127 | 22 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | transcription factor binding | 8.53e-03 | 753 | 22 | 4 | GO:0008134 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | VEZF1 NFAT5 CLOCK RFX3 ZNF384 ZFHX3 AR PRDM10 KMT2D MAML2 SUPT20H EPC1 TCF20 | 1.57e-10 | 1390 | 22 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin remodeling | 7.99e-06 | 741 | 22 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.74e-05 | 896 | 22 | 7 | GO:0006325 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell development | 4.86e-05 | 10 | 22 | 2 | GO:2000074 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 5.50e-05 | 999 | 22 | 7 | GO:0071824 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 7.12e-05 | 12 | 22 | 2 | GO:0033148 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.05e-04 | 87 | 22 | 3 | GO:0033143 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 1.64e-04 | 18 | 22 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 1.72e-04 | 269 | 22 | 4 | GO:0002064 | |
| GeneOntologyBiologicalProcess | DNA damage response | 3.91e-04 | 959 | 22 | 6 | GO:0006974 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 3.94e-04 | 136 | 22 | 3 | GO:0030518 | |
| GeneOntologyBiologicalProcess | type B pancreatic cell development | 4.33e-04 | 29 | 22 | 2 | GO:0003323 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 5.77e-04 | 155 | 22 | 3 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 6.69e-04 | 36 | 22 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | type B pancreatic cell differentiation | 9.11e-04 | 42 | 22 | 2 | GO:0003309 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell development | 9.55e-04 | 43 | 22 | 2 | GO:0002068 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 9.81e-04 | 1141 | 22 | 6 | GO:0045597 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 1.00e-03 | 44 | 22 | 2 | GO:1905168 | |
| GeneOntologyBiologicalProcess | regulation of calcineurin-NFAT signaling cascade | 1.00e-03 | 44 | 22 | 2 | GO:0070884 | |
| GeneOntologyBiologicalProcess | regulation of calcineurin-mediated signaling | 1.05e-03 | 45 | 22 | 2 | GO:0106056 | |
| GeneOntologyBiologicalProcess | enteroendocrine cell differentiation | 1.24e-03 | 49 | 22 | 2 | GO:0035883 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.24e-03 | 202 | 22 | 3 | GO:0141193 | |
| GeneOntologyBiologicalProcess | calcineurin-NFAT signaling cascade | 1.50e-03 | 54 | 22 | 2 | GO:0033173 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 1.67e-03 | 57 | 22 | 2 | GO:0030520 | |
| GeneOntologyBiologicalProcess | calcineurin-mediated signaling | 1.73e-03 | 58 | 22 | 2 | GO:0097720 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.89e-03 | 234 | 22 | 3 | GO:0006282 | |
| GeneOntologyBiologicalProcess | endocrine pancreas development | 1.91e-03 | 61 | 22 | 2 | GO:0031018 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.01e-03 | 239 | 22 | 3 | GO:0071383 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.13e-03 | 244 | 22 | 3 | GO:0009755 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell development | 2.44e-03 | 69 | 22 | 2 | GO:0002066 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 2.80e-03 | 1399 | 22 | 6 | GO:0045892 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 2.87e-03 | 75 | 22 | 2 | GO:0032922 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 2.94e-03 | 1413 | 22 | 6 | GO:1902679 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 3.26e-03 | 80 | 22 | 2 | GO:0045911 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 3.38e-03 | 598 | 22 | 4 | GO:0080135 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell differentiation | 3.43e-03 | 82 | 22 | 2 | GO:0030858 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 3.51e-03 | 83 | 22 | 2 | GO:0010569 | |
| GeneOntologyCellularComponent | chromatin | EP400 NFAT5 CLOCK RFX3 ZFHX3 AR CHD1 PRDM10 PHC1 SUPT20H EPC1 | 3.93e-08 | 1480 | 21 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear body | 1.45e-06 | 903 | 21 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.10e-04 | 94 | 21 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.49e-04 | 104 | 21 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.71e-04 | 109 | 21 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.58e-04 | 596 | 21 | 5 | GO:0005667 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 4.68e-04 | 32 | 21 | 2 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 4.68e-04 | 32 | 21 | 2 | GO:0035267 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 9.27e-04 | 45 | 21 | 2 | GO:1902562 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.01e-03 | 254 | 21 | 3 | GO:0000228 | |
| GeneOntologyCellularComponent | transferase complex | 2.25e-03 | 963 | 21 | 5 | GO:1990234 | |
| GeneOntologyCellularComponent | nucleosome | 8.37e-03 | 138 | 21 | 2 | GO:0000786 | |
| GeneOntologyCellularComponent | nuclear speck | 8.78e-03 | 431 | 21 | 3 | GO:0016607 | |
| HumanPheno | Ventral shortening of foreskin | 3.47e-06 | 2 | 10 | 2 | HP:0012435 | |
| HumanPheno | Blind vagina | 3.46e-05 | 5 | 10 | 2 | HP:0040314 | |
| HumanPheno | Androgen insufficiency | 3.46e-05 | 5 | 10 | 2 | HP:0008226 | |
| HumanPheno | Abnormal preputium morphology | 3.76e-05 | 36 | 10 | 3 | HP:0100587 | |
| HumanPheno | Urethral diverticulum | 5.18e-05 | 6 | 10 | 2 | HP:0008722 | |
| MousePheno | advanced circadian behavior phase | 1.75e-05 | 5 | 19 | 2 | MP:0020474 | |
| MousePheno | arrhythmic circadian behavior persistence | 6.27e-05 | 9 | 19 | 2 | MP:0020472 | |
| MousePheno | abnormal circadian behavior persistence | 9.56e-05 | 11 | 19 | 2 | MP:0020471 | |
| MousePheno | prolonged circadian behavior period | 1.58e-04 | 14 | 19 | 2 | MP:0020469 | |
| Domain | EPHD | 3.02e-04 | 22 | 22 | 2 | PS51805 | |
| Domain | SNF2_N | 6.43e-04 | 32 | 22 | 2 | PF00176 | |
| Domain | SNF2_N | 6.43e-04 | 32 | 22 | 2 | IPR000330 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 7.70e-04 | 35 | 22 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 9.08e-04 | 38 | 22 | 2 | PS00690 | |
| Domain | - | 9.85e-04 | 679 | 22 | 5 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.08e-03 | 693 | 22 | 5 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.09e-03 | 694 | 22 | 5 | IPR013087 | |
| Domain | SET_dom | 1.57e-03 | 50 | 22 | 2 | IPR001214 | |
| Domain | SET | 1.57e-03 | 50 | 22 | 2 | PS50280 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.77e-03 | 775 | 22 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.79e-03 | 777 | 22 | 5 | PS00028 | |
| Domain | Znf_C2H2-like | 2.00e-03 | 796 | 22 | 5 | IPR015880 | |
| Domain | Znf_C2H2 | 2.10e-03 | 805 | 22 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.13e-03 | 808 | 22 | 5 | SM00355 | |
| Domain | PHD | 4.87e-03 | 89 | 22 | 2 | SM00249 | |
| Domain | Znf_PHD | 5.09e-03 | 91 | 22 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.53e-03 | 95 | 22 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 5.65e-03 | 96 | 22 | 2 | PS01359 | |
| Domain | Helicase_C | 6.97e-03 | 107 | 22 | 2 | PF00271 | |
| Domain | HELICc | 6.97e-03 | 107 | 22 | 2 | SM00490 | |
| Domain | Helicase_C | 7.10e-03 | 108 | 22 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 7.22e-03 | 109 | 22 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 7.22e-03 | 109 | 22 | 2 | PS51192 | |
| Domain | DEXDc | 7.22e-03 | 109 | 22 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 7.35e-03 | 110 | 22 | 2 | IPR014001 | |
| Domain | Znf_FYVE_PHD | 1.28e-02 | 147 | 22 | 2 | IPR011011 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.01e-06 | 768 | 18 | 8 | MM14851 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.68e-05 | 1022 | 18 | 8 | MM15436 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.80e-05 | 272 | 18 | 5 | M29619 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 2.71e-05 | 142 | 18 | 4 | M27233 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 6.89e-05 | 10 | 18 | 2 | MM15535 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.01e-04 | 12 | 18 | 2 | M27159 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.16e-04 | 76 | 18 | 3 | MM15520 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.39e-04 | 14 | 18 | 2 | M27808 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 1.53e-04 | 1387 | 18 | 8 | M734 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.83e-04 | 16 | 18 | 2 | M27121 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.32e-04 | 96 | 18 | 3 | M27784 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.33e-04 | 18 | 18 | 2 | MM14775 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.89e-04 | 20 | 18 | 2 | M27881 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.83e-04 | 23 | 18 | 2 | MM14954 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 4.54e-04 | 25 | 18 | 2 | MM15546 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.54e-04 | 25 | 18 | 2 | M27880 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.71e-04 | 28 | 18 | 2 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 7.94e-04 | 33 | 18 | 2 | M604 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 8.43e-04 | 34 | 18 | 2 | M27826 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.11e-03 | 39 | 18 | 2 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.29e-03 | 42 | 18 | 2 | M17541 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.61e-03 | 47 | 18 | 2 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.68e-03 | 48 | 18 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.68e-03 | 48 | 18 | 2 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.75e-03 | 49 | 18 | 2 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 2.44e-03 | 58 | 18 | 2 | M29616 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.70e-03 | 61 | 18 | 2 | M39540 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 3.43e-03 | 69 | 18 | 2 | M46439 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.94e-03 | 74 | 18 | 2 | M616 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 4.81e-03 | 82 | 18 | 2 | M594 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 4.81e-03 | 82 | 18 | 2 | MM15922 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 6.20e-03 | 301 | 18 | 3 | MM15983 | |
| Pathway | WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM | 8.96e-03 | 113 | 18 | 2 | M48336 | |
| Pubmed | 1.05e-09 | 23 | 22 | 4 | 9225980 | ||
| Pubmed | 1.33e-08 | 268 | 22 | 6 | 33640491 | ||
| Pubmed | 7.92e-08 | 65 | 22 | 4 | 22496869 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.01e-07 | 69 | 22 | 4 | 28481362 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.38e-07 | 398 | 22 | 6 | 35016035 | |
| Pubmed | 2.13e-07 | 83 | 22 | 4 | 28794006 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 34953044 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 36898841 | ||
| Pubmed | 4.48e-07 | 808 | 22 | 7 | 20412781 | ||
| Pubmed | The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs. | 5.66e-07 | 26 | 22 | 3 | 24391519 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 7.21e-07 | 1294 | 22 | 8 | 30804502 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 9.78e-07 | 908 | 22 | 7 | 19274049 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 21935435 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 30930119 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.46e-06 | 134 | 22 | 4 | 25452129 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.02e-06 | 341 | 22 | 5 | 32971831 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 26751641 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.33e-06 | 351 | 22 | 5 | 38297188 | |
| Pubmed | 2.74e-06 | 157 | 22 | 4 | 30186101 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 8896557 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 28445460 | ||
| Pubmed | The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1). | 8.01e-06 | 7 | 22 | 2 | 10860780 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 11121205 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.04e-05 | 220 | 22 | 4 | 35785414 | |
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 1.07e-05 | 8 | 22 | 2 | 22722839 | |
| Pubmed | 1.08e-05 | 222 | 22 | 4 | 37071664 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 9535906 | ||
| Pubmed | 1.62e-05 | 78 | 22 | 3 | 28611094 | ||
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 18087039 | ||
| Pubmed | 1.93e-05 | 1429 | 22 | 7 | 35140242 | ||
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 15196461 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.15e-05 | 954 | 22 | 6 | 36373674 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.71e-05 | 583 | 22 | 5 | 29844126 | |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 2.80e-05 | 283 | 22 | 4 | 18854154 | |
| Pubmed | 2.97e-05 | 13 | 22 | 2 | 16510874 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.31e-05 | 608 | 22 | 5 | 36089195 | |
| Pubmed | 3.99e-05 | 15 | 22 | 2 | 16510875 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.35e-05 | 1082 | 22 | 6 | 38697112 | |
| Pubmed | 5.81e-05 | 18 | 22 | 2 | 23087174 | ||
| Pubmed | 6.86e-05 | 709 | 22 | 5 | 22988430 | ||
| Pubmed | 7.96e-05 | 21 | 22 | 2 | 22467210 | ||
| Pubmed | 8.76e-05 | 22 | 22 | 2 | 12963728 | ||
| Pubmed | 9.59e-05 | 23 | 22 | 2 | 26002199 | ||
| Pubmed | MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks. | 9.59e-05 | 23 | 22 | 2 | 20332121 | |
| Pubmed | 9.59e-05 | 23 | 22 | 2 | 14966270 | ||
| Pubmed | 9.59e-05 | 23 | 22 | 2 | 31281901 | ||
| Pubmed | 1.03e-04 | 396 | 22 | 4 | 26687479 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.18e-04 | 410 | 22 | 4 | 26949251 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 1.19e-04 | 152 | 22 | 3 | 28192407 | |
| Pubmed | 1.27e-04 | 418 | 22 | 4 | 34709266 | ||
| Pubmed | 1.34e-04 | 1327 | 22 | 6 | 32694731 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.57e-04 | 167 | 22 | 3 | 20362541 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.60e-04 | 444 | 22 | 4 | 34795231 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.67e-04 | 857 | 22 | 5 | 25609649 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.86e-04 | 877 | 22 | 5 | 20211142 | |
| Pubmed | 2.24e-04 | 35 | 22 | 2 | 20946988 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.49e-04 | 934 | 22 | 5 | 33916271 | |
| Pubmed | 2.59e-04 | 1497 | 22 | 6 | 31527615 | ||
| Pubmed | 2.65e-04 | 38 | 22 | 2 | 28218735 | ||
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 2.65e-04 | 38 | 22 | 2 | 27930960 | |
| Pubmed | 2.65e-04 | 38 | 22 | 2 | 27153538 | ||
| Pubmed | 3.24e-04 | 42 | 22 | 2 | 35705031 | ||
| Pubmed | Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis. | 3.24e-04 | 42 | 22 | 2 | 29028833 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 3.46e-04 | 544 | 22 | 4 | 28473536 | |
| Pubmed | 4.23e-04 | 48 | 22 | 2 | 24302573 | ||
| Pubmed | 4.65e-04 | 242 | 22 | 3 | 34011540 | ||
| Pubmed | 5.34e-04 | 1103 | 22 | 5 | 34189442 | ||
| Pubmed | 5.97e-04 | 57 | 22 | 2 | 18022353 | ||
| Interaction | FEV interactions | 4.64e-08 | 203 | 21 | 6 | int:FEV | |
| Interaction | TLE3 interactions | 6.91e-08 | 376 | 21 | 7 | int:TLE3 | |
| Interaction | SNRNP40 interactions | 1.35e-07 | 637 | 21 | 8 | int:SNRNP40 | |
| Interaction | PLAC1 interactions | 1.95e-06 | 24 | 21 | 3 | int:PLAC1 | |
| Interaction | CRX interactions | 5.28e-06 | 254 | 21 | 5 | int:CRX | |
| Interaction | ELF4 interactions | 5.59e-06 | 115 | 21 | 4 | int:ELF4 | |
| Interaction | MED23 interactions | 6.60e-06 | 266 | 21 | 5 | int:MED23 | |
| Interaction | MYCL interactions | 1.64e-05 | 48 | 21 | 3 | int:MYCL | |
| Interaction | POU5F1 interactions | 2.16e-05 | 584 | 21 | 6 | int:POU5F1 | |
| Interaction | EGR2 interactions | 2.68e-05 | 171 | 21 | 4 | int:EGR2 | |
| Interaction | KDM1A interactions | 3.09e-05 | 941 | 21 | 7 | int:KDM1A | |
| Interaction | NUP43 interactions | 3.17e-05 | 625 | 21 | 6 | int:NUP43 | |
| Interaction | JAZF1 interactions | 3.38e-05 | 61 | 21 | 3 | int:JAZF1 | |
| Interaction | LHX3 interactions | 3.64e-05 | 185 | 21 | 4 | int:LHX3 | |
| Interaction | HNF1B interactions | 4.04e-05 | 190 | 21 | 4 | int:HNF1B | |
| Interaction | AR interactions | 4.34e-05 | 992 | 21 | 7 | int:AR | |
| Interaction | KLF5 interactions | 4.47e-05 | 195 | 21 | 4 | int:KLF5 | |
| Interaction | CIC interactions | 4.79e-05 | 673 | 21 | 6 | int:CIC | |
| Interaction | SOX2 interactions | 5.34e-05 | 1422 | 21 | 8 | int:SOX2 | |
| Interaction | PDE6A interactions | 5.66e-05 | 11 | 21 | 2 | int:PDE6A | |
| Interaction | EPC1 interactions | 7.90e-05 | 81 | 21 | 3 | int:EPC1 | |
| Interaction | NFIX interactions | 8.07e-05 | 227 | 21 | 4 | int:NFIX | |
| Interaction | KLF3 interactions | 8.21e-05 | 228 | 21 | 4 | int:KLF3 | |
| Interaction | H3-3A interactions | 8.68e-05 | 749 | 21 | 6 | int:H3-3A | |
| Interaction | HDAC1 interactions | 8.76e-05 | 1108 | 21 | 7 | int:HDAC1 | |
| Interaction | ASF1A interactions | 1.15e-04 | 249 | 21 | 4 | int:ASF1A | |
| Interaction | MAX interactions | 1.19e-04 | 251 | 21 | 4 | int:MAX | |
| Interaction | RBPJ interactions | 1.25e-04 | 254 | 21 | 4 | int:RBPJ | |
| Interaction | KLF6 interactions | 1.27e-04 | 95 | 21 | 3 | int:KLF6 | |
| Interaction | KAT2B interactions | 1.28e-04 | 256 | 21 | 4 | int:KAT2B | |
| Interaction | H3C3 interactions | 1.29e-04 | 495 | 21 | 5 | int:H3C3 | |
| Interaction | TRIM27 interactions | 1.54e-04 | 514 | 21 | 5 | int:TRIM27 | |
| Interaction | HNF4A interactions | 1.69e-04 | 275 | 21 | 4 | int:HNF4A | |
| Interaction | CEBPA interactions | 1.82e-04 | 1245 | 21 | 7 | int:CEBPA | |
| Interaction | MRGBP interactions | 1.91e-04 | 109 | 21 | 3 | int:MRGBP | |
| Interaction | KLF15 interactions | 2.07e-04 | 290 | 21 | 4 | int:KLF15 | |
| Interaction | TLX3 interactions | 2.10e-04 | 291 | 21 | 4 | int:TLX3 | |
| Interaction | MAGED1 interactions | 2.21e-04 | 295 | 21 | 4 | int:MAGED1 | |
| Interaction | TAF6L interactions | 2.23e-04 | 115 | 21 | 3 | int:TAF6L | |
| Interaction | SP7 interactions | 2.48e-04 | 304 | 21 | 4 | int:SP7 | |
| Interaction | SLX4 interactions | 2.53e-04 | 572 | 21 | 5 | int:SLX4 | |
| Interaction | ELK3 interactions | 2.53e-04 | 120 | 21 | 3 | int:ELK3 | |
| Interaction | PARP1 interactions | 2.57e-04 | 1316 | 21 | 7 | int:PARP1 | |
| Interaction | ETS1 interactions | 2.59e-04 | 121 | 21 | 3 | int:ETS1 | |
| Interaction | H2BC8 interactions | 2.61e-04 | 576 | 21 | 5 | int:H2BC8 | |
| Interaction | CREBBP interactions | 3.13e-04 | 599 | 21 | 5 | int:CREBBP | |
| Interaction | PAX9 interactions | 3.20e-04 | 130 | 21 | 3 | int:PAX9 | |
| Interaction | KLF8 interactions | 3.35e-04 | 329 | 21 | 4 | int:KLF8 | |
| Interaction | CSNK2B interactions | 3.80e-04 | 625 | 21 | 5 | int:CSNK2B | |
| Interaction | PHF21A interactions | 3.92e-04 | 343 | 21 | 4 | int:PHF21A | |
| Interaction | RNF4 interactions | 3.96e-04 | 1412 | 21 | 7 | int:RNF4 | |
| Interaction | TLX2 interactions | 4.15e-04 | 142 | 21 | 3 | int:TLX2 | |
| Interaction | SMC5 interactions | 4.19e-04 | 1000 | 21 | 6 | int:SMC5 | |
| Interaction | CBX3 interactions | 4.42e-04 | 646 | 21 | 5 | int:CBX3 | |
| Interaction | CEBPB interactions | 4.52e-04 | 1443 | 21 | 7 | int:CEBPB | |
| Interaction | KAT5 interactions | 4.61e-04 | 358 | 21 | 4 | int:KAT5 | |
| Interaction | PYHIN1 interactions | 4.61e-04 | 358 | 21 | 4 | int:PYHIN1 | |
| Interaction | POU6F2 interactions | 4.68e-04 | 148 | 21 | 3 | int:POU6F2 | |
| Interaction | BRD8 interactions | 4.78e-04 | 149 | 21 | 3 | int:BRD8 | |
| Interaction | MEN1 interactions | 4.89e-04 | 1029 | 21 | 6 | int:MEN1 | |
| Interaction | PAX6 interactions | 5.01e-04 | 366 | 21 | 4 | int:PAX6 | |
| Interaction | ETV5 interactions | 5.36e-04 | 33 | 21 | 2 | int:ETV5 | |
| Interaction | ELF2 interactions | 5.46e-04 | 156 | 21 | 3 | int:ELF2 | |
| Interaction | FASN interactions | 5.78e-04 | 1062 | 21 | 6 | int:FASN | |
| Interaction | KLF4 interactions | 5.88e-04 | 160 | 21 | 3 | int:KLF4 | |
| Interaction | SOX5 interactions | 6.10e-04 | 162 | 21 | 3 | int:SOX5 | |
| Interaction | FHL2 interactions | 6.74e-04 | 396 | 21 | 4 | int:FHL2 | |
| Interaction | YAP1 interactions | 6.80e-04 | 1095 | 21 | 6 | int:YAP1 | |
| Interaction | TLX1 interactions | 7.63e-04 | 175 | 21 | 3 | int:TLX1 | |
| Interaction | MDC1 interactions | 7.96e-04 | 414 | 21 | 4 | int:MDC1 | |
| Interaction | H2BC1 interactions | 8.01e-04 | 178 | 21 | 3 | int:H2BC1 | |
| Interaction | NKX2-1 interactions | 8.28e-04 | 180 | 21 | 3 | int:NKX2-1 | |
| Interaction | YEATS4 interactions | 8.55e-04 | 182 | 21 | 3 | int:YEATS4 | |
| Interaction | WWTR1 interactions | 8.55e-04 | 422 | 21 | 4 | int:WWTR1 | |
| Interaction | FOXR2 interactions | 8.68e-04 | 42 | 21 | 2 | int:FOXR2 | |
| Interaction | LHX2 interactions | 8.68e-04 | 183 | 21 | 3 | int:LHX2 | |
| Interaction | EP400 interactions | 8.82e-04 | 184 | 21 | 3 | int:EP400 | |
| Interaction | E2F6 interactions | 8.96e-04 | 185 | 21 | 3 | int:E2F6 | |
| Interaction | HIVEP1 interactions | 9.10e-04 | 186 | 21 | 3 | int:HIVEP1 | |
| Interaction | FOXR1 interactions | 9.53e-04 | 44 | 21 | 2 | int:FOXR1 | |
| Interaction | DMAP1 interactions | 9.83e-04 | 191 | 21 | 3 | int:DMAP1 | |
| Interaction | PRPF40A interactions | 1.05e-03 | 446 | 21 | 4 | int:PRPF40A | |
| Interaction | TRRAP interactions | 1.10e-03 | 790 | 21 | 5 | int:TRRAP | |
| Interaction | PYGO2 interactions | 1.13e-03 | 48 | 21 | 2 | int:PYGO2 | |
| Interaction | DPY30 interactions | 1.19e-03 | 204 | 21 | 3 | int:DPY30 | |
| Interaction | PAGR1 interactions | 1.28e-03 | 51 | 21 | 2 | int:PAGR1 | |
| Interaction | NANOG interactions | 1.39e-03 | 481 | 21 | 4 | int:NANOG | |
| Interaction | RELA interactions | 1.43e-03 | 485 | 21 | 4 | int:RELA | |
| Interaction | POLR1G interactions | 1.48e-03 | 489 | 21 | 4 | int:POLR1G | |
| Interaction | MORF4L1 interactions | 1.50e-03 | 221 | 21 | 3 | int:MORF4L1 | |
| Interaction | RCOR1 interactions | 1.53e-03 | 494 | 21 | 4 | int:RCOR1 | |
| Interaction | ERG interactions | 1.53e-03 | 223 | 21 | 3 | int:ERG | |
| Interaction | MECP2 interactions | 1.58e-03 | 1287 | 21 | 6 | int:MECP2 | |
| Interaction | HDAC2 interactions | 1.65e-03 | 865 | 21 | 5 | int:HDAC2 | |
| Interaction | RNF2 interactions | 1.66e-03 | 866 | 21 | 5 | int:RNF2 | |
| Interaction | H2AC4 interactions | 1.67e-03 | 506 | 21 | 4 | int:H2AC4 | |
| Interaction | MBTD1 interactions | 1.71e-03 | 59 | 21 | 2 | int:MBTD1 | |
| Interaction | CTR9 interactions | 1.74e-03 | 233 | 21 | 3 | int:CTR9 | |
| Interaction | RPS9 interactions | 1.79e-03 | 515 | 21 | 4 | int:RPS9 | |
| Interaction | H2BC10 interactions | 1.82e-03 | 61 | 21 | 2 | int:H2BC10 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 3.46e-03 | 183 | 22 | 2 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 1.23e-02 | 353 | 22 | 2 | chr12p13 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.68e-09 | 25 | 17 | 4 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.05e-04 | 718 | 17 | 5 | 28 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 2.12e-05 | 199 | 22 | 4 | M3151 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 5.68e-05 | 856 | 22 | 6 | M4500 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 4.10e-04 | 175 | 22 | 3 | M6723 | |
| Coexpression | GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP | 5.14e-04 | 189 | 22 | 3 | M4921 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 5.14e-04 | 189 | 22 | 3 | M3112 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 5.38e-04 | 192 | 22 | 3 | M8272 | |
| Coexpression | VANTVEER_BREAST_CANCER_BRCA1_DN | 5.41e-04 | 41 | 22 | 2 | M3464 | |
| Coexpression | CHANGOLKAR_H2AFY_TARGETS_DN | 5.67e-04 | 42 | 22 | 2 | M2290 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN | 5.88e-04 | 198 | 22 | 3 | M5701 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN | 5.88e-04 | 198 | 22 | 3 | M7480 | |
| Coexpression | GSE11057_CD4_CENT_MEM_VS_PBMC_UP | 5.88e-04 | 198 | 22 | 3 | M3116 | |
| Coexpression | CHANGOLKAR_H2AFY_TARGETS_DN | 5.95e-04 | 43 | 22 | 2 | MM902 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 6.06e-04 | 200 | 22 | 3 | M5055 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 6.06e-04 | 200 | 22 | 3 | M9449 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 6.06e-04 | 200 | 22 | 3 | M9439 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 6.06e-04 | 200 | 22 | 3 | M9463 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 6.06e-04 | 200 | 22 | 3 | M8050 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP | 6.06e-04 | 200 | 22 | 3 | M8495 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN | 6.06e-04 | 200 | 22 | 3 | M330 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 6.06e-04 | 200 | 22 | 3 | M331 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 6.06e-04 | 200 | 22 | 3 | M7518 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_UP | 6.06e-04 | 200 | 22 | 3 | M5157 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP | 6.06e-04 | 200 | 22 | 3 | M8733 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 6.35e-04 | 482 | 22 | 4 | M12144 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 5.44e-07 | 135 | 22 | 4 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 160 | 22 | 3 | b3f7ef7e682b48a83ca425f5c439336e96168300 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.58e-05 | 176 | 22 | 3 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 186 | 22 | 3 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.09e-04 | 191 | 22 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 192 | 22 | 3 | b2d9cc2a013012b25b458d4dc77be63e1c2144da | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 192 | 22 | 3 | b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 199 | 22 | 3 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| Computational | Neighborhood of RBM8A | 3.10e-04 | 81 | 18 | 3 | GCM_RBM8A | |
| Computational | Neighborhood of MSH3 | 6.07e-04 | 243 | 18 | 4 | MORF_MSH3 | |
| Drug | glutamin | 3.78e-06 | 461 | 22 | 6 | CID000000738 | |
| Drug | 17-alpha-Hydroxyprogesterone | 3.20e-05 | 9 | 22 | 2 | ctd:D019326 | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 22 | 4 | 6228_DN | |
| Drug | canrenone | 1.06e-04 | 16 | 22 | 2 | CID000013789 | |
| Drug | AC1L9FY1 | 1.23e-04 | 101 | 22 | 3 | CID000444218 | |
| Drug | AC1L1HD4 | 1.85e-04 | 21 | 22 | 2 | CID000004079 | |
| Drug | reversine | 2.64e-04 | 25 | 22 | 2 | CID000210332 | |
| Drug | trenbolone acetate | 3.56e-04 | 29 | 22 | 2 | CID000066359 | |
| Drug | tert-butyl glutaminate | 4.91e-04 | 34 | 22 | 2 | CID003450458 | |
| Drug | Methylene Chloride | 5.02e-04 | 163 | 22 | 3 | ctd:D008752 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.77e-04 | 171 | 22 | 3 | 6879_DN | |
| Drug | 11-ketotestosterone | 6.13e-04 | 38 | 22 | 2 | CID000104796 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 1652_UP | |
| Drug | 7 alpha, 17 alpha-dimethyl-19-nortestosterone | 8.23e-04 | 44 | 22 | 2 | CID000019454 | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 6210_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 8.32e-04 | 194 | 22 | 3 | 1060_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 3042_UP | |
| Drug | Androstenedione | 8.60e-04 | 45 | 22 | 2 | ctd:D000735 | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 6935_DN | |
| Drug | STOCK1N-35874; Down 200; 14uM; PC3; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 6561_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 6230_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 2667_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 6989_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 7126_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; HL60; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2543_UP | |
| Disease | hypospadias (is_implicated_in) | 1.35e-05 | 8 | 21 | 2 | DOID:10892 (is_implicated_in) | |
| Disease | Malignant tumor of prostate | 1.73e-05 | 9 | 21 | 2 | cv:C0376358 | |
| Disease | prostate cancer (is_implicated_in) | 7.67e-05 | 117 | 21 | 3 | DOID:10283 (is_implicated_in) | |
| Disease | Neoplasm of the genitourinary tract | 1.32e-04 | 24 | 21 | 2 | cv:C0042065 | |
| Disease | prostate cancer (implicated_via_orthology) | 2.51e-04 | 33 | 21 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | asparagine measurement | 3.89e-04 | 41 | 21 | 2 | EFO_0009766 | |
| Disease | Male sterility | 5.34e-04 | 48 | 21 | 2 | C0917731 | |
| Disease | Male infertility | 5.34e-04 | 48 | 21 | 2 | C0021364 | |
| Disease | Subfertility, Male | 5.34e-04 | 48 | 21 | 2 | C0848676 | |
| Disease | cognitive inhibition measurement | 5.79e-04 | 50 | 21 | 2 | EFO_0007969 | |
| Disease | Mental Depression | 7.47e-04 | 254 | 21 | 3 | C0011570 | |
| Disease | Prostatic Neoplasms | 8.49e-04 | 616 | 21 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.49e-04 | 616 | 21 | 4 | C0376358 | |
| Disease | breast carcinoma (is_marker_for) | 1.01e-03 | 66 | 21 | 2 | DOID:3459 (is_marker_for) | |
| Disease | Depressive disorder | 1.09e-03 | 289 | 21 | 3 | C0011581 | |
| Disease | vital capacity | 1.48e-03 | 1236 | 21 | 5 | EFO_0004312 | |
| Disease | balding measurement | 2.14e-03 | 792 | 21 | 4 | EFO_0007825 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQQQQQQQQTTTTSQ | 2776 | Q96L91 | |
| QQLAQIQQQQANSNS | 601 | Q9H2F5 | |
| QQQQQQQQHQASSNS | 106 | O14646 | |
| SQVAKAQQQQQQQQQ | 421 | Q9Y6R0 | |
| QQQQQQQQQQGDLSG | 296 | P54252 | |
| QQQQQQQQQQETSPR | 71 | P10275 | |
| QQQQQETSPRQQQQQ | 76 | P10275 | |
| SSTQGQALQQQQQQQ | 1011 | Q9NQV6 | |
| QALQQQQQQQQNSSV | 1016 | Q9NQV6 | |
| QSENTLSNQQQQQQQ | 871 | O94916 | |
| QQQQQQSILFSNQNT | 1261 | O94916 | |
| QQQQQQQQQQQSSIS | 611 | Q8IZL2 | |
| QQQQQQSSISAQQQQ | 616 | Q8IZL2 | |
| AQQQQQQQSSISAQQ | 626 | Q8IZL2 | |
| QQQSSISAQQQQQQQ | 631 | Q8IZL2 | |
| TSLAQQQQQQQQQQQ | 326 | Q8IWX8 | |
| TSNLLSQQQQQQQQQ | 486 | Q13495 | |
| TATLQLQQQQQQQQQ | 591 | Q13495 | |
| VQQQVQQVQTVQQVQ | 36 | P48380 | |
| QQQQQQQQQASATGS | 41 | Q9BVH7 | |
| QQSQTLSVTQQQQQQ | 746 | O15516 | |
| ASQASQQQQQQQQQQ | 496 | Q8TF68 | |
| ETSNQKQQQQQQQQQ | 331 | Q14119 | |
| QLSSAFQQQQQQIQQ | 721 | Q8NEM7 | |
| QQQQQQQQQPQATTL | 431 | P78364 | |
| QYQQQASSQQQQQQV | 166 | Q9UGU0 | |
| QQQQEQLQTQQAQEQ | 171 | P0CG23 | |
| QQQQQQAQTLAQAQA | 1736 | Q15911 | |
| QQQQQQLWQQQQATA | 2811 | O14686 |